QQQ   281.66 (+0.42%)
AAPL   115.76 (+0.62%)
MSFT   211.92 (+0.88%)
FB   278.33 (+0.44%)
GOOGL   1,582.76 (-0.10%)
AMZN   3,240.00 (+1.03%)
TSLA   426.97 (+1.59%)
NVDA   531.30 (+1.07%)
BABA   309.33 (+0.80%)
CGC   18.98 (+2.43%)
GE   7.28 (-1.36%)
MU   51.92 (-0.42%)
AMD   78.67 (-4.33%)
T   27.08 (-1.10%)
F   7.99 (-0.50%)
ACB   4.31 (-2.05%)
GILD   60.06 (+0.17%)
NFLX   486.24 (-0.41%)
NIO   27.26 (+4.81%)
BA   157.98 (-1.77%)
DIS   123.91 (-0.12%)
QQQ   281.66 (+0.42%)
AAPL   115.76 (+0.62%)
MSFT   211.92 (+0.88%)
FB   278.33 (+0.44%)
GOOGL   1,582.76 (-0.10%)
AMZN   3,240.00 (+1.03%)
TSLA   426.97 (+1.59%)
NVDA   531.30 (+1.07%)
BABA   309.33 (+0.80%)
CGC   18.98 (+2.43%)
GE   7.28 (-1.36%)
MU   51.92 (-0.42%)
AMD   78.67 (-4.33%)
T   27.08 (-1.10%)
F   7.99 (-0.50%)
ACB   4.31 (-2.05%)
GILD   60.06 (+0.17%)
NFLX   486.24 (-0.41%)
NIO   27.26 (+4.81%)
BA   157.98 (-1.77%)
DIS   123.91 (-0.12%)
QQQ   281.66 (+0.42%)
AAPL   115.76 (+0.62%)
MSFT   211.92 (+0.88%)
FB   278.33 (+0.44%)
GOOGL   1,582.76 (-0.10%)
AMZN   3,240.00 (+1.03%)
TSLA   426.97 (+1.59%)
NVDA   531.30 (+1.07%)
BABA   309.33 (+0.80%)
CGC   18.98 (+2.43%)
GE   7.28 (-1.36%)
MU   51.92 (-0.42%)
AMD   78.67 (-4.33%)
T   27.08 (-1.10%)
F   7.99 (-0.50%)
ACB   4.31 (-2.05%)
GILD   60.06 (+0.17%)
NFLX   486.24 (-0.41%)
NIO   27.26 (+4.81%)
BA   157.98 (-1.77%)
DIS   123.91 (-0.12%)
QQQ   281.66 (+0.42%)
AAPL   115.76 (+0.62%)
MSFT   211.92 (+0.88%)
FB   278.33 (+0.44%)
GOOGL   1,582.76 (-0.10%)
AMZN   3,240.00 (+1.03%)
TSLA   426.97 (+1.59%)
NVDA   531.30 (+1.07%)
BABA   309.33 (+0.80%)
CGC   18.98 (+2.43%)
GE   7.28 (-1.36%)
MU   51.92 (-0.42%)
AMD   78.67 (-4.33%)
T   27.08 (-1.10%)
F   7.99 (-0.50%)
ACB   4.31 (-2.05%)
GILD   60.06 (+0.17%)
NFLX   486.24 (-0.41%)
NIO   27.26 (+4.81%)
BA   157.98 (-1.77%)
DIS   123.91 (-0.12%)
Log in
NASDAQ:IRTC

Irhythm Technologies Stock Forecast, Price & News

$224.64
+6.20 (+2.84 %)
(As of 10/27/2020 09:50 AM ET)
Add
Compare
Today's Range
$221.45
Now: $224.64
$224.64
50-Day Range
$207.00
MA: $228.77
$259.50
52-Week Range
$56.24
Now: $224.64
$261.05
Volume260 shs
Average Volume381,079 shs
Market Capitalization$6.48 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.74
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. Its Zio XT monitor, a single-use, wire-free, and wearable patch-based biosensor, records patient's heartbeats and ECG data. The company was founded in 2006 and is headquartered in San Francisco, California.
Read More
Irhythm Technologies logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.19 out of 5 stars

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:IRTC
CUSIPN/A
Phone415-632-5700
Employees748

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$214.55 million
Book Value$5.09 per share

Profitability

Net Income$-54,570,000.00

Miscellaneous

Market Cap$6.48 billion
Next Earnings Date11/5/2020 (Confirmed)
OptionableOptionable
$224.64
+6.20 (+2.84 %)
(As of 10/27/2020 09:50 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IRTC News and Ratings via Email

Sign-up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Irhythm Technologies (NASDAQ:IRTC) Frequently Asked Questions

How has Irhythm Technologies' stock been impacted by COVID-19?

Irhythm Technologies' stock was trading at $85.54 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, IRTC shares have increased by 162.6% and is now trading at $224.64.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Irhythm Technologies?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Irhythm Technologies in the last year. There are currently 2 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Irhythm Technologies
.

When is Irhythm Technologies' next earnings date?

Irhythm Technologies is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Irhythm Technologies
.

How can I listen to Irhythm Technologies' earnings call?

Irhythm Technologies will be holding an earnings conference call on Thursday, November 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Irhythm Technologies' earnings last quarter?

Irhythm Technologies Inc (NASDAQ:IRTC) released its quarterly earnings data on Thursday, August, 6th. The company reported ($0.75) EPS for the quarter, beating the consensus estimate of ($0.84) by $0.09. The business had revenue of $50.88 million for the quarter, compared to the consensus estimate of $42.18 million. Irhythm Technologies had a negative net margin of 28.50% and a negative return on equity of 50.23%. The business's revenue was down 3.0% on a year-over-year basis. During the same quarter last year, the business earned ($0.43) EPS.
View Irhythm Technologies' earnings history
.

What price target have analysts set for IRTC?

12 equities research analysts have issued twelve-month price targets for Irhythm Technologies' shares. Their forecasts range from $130.00 to $250.00. On average, they anticipate Irhythm Technologies' stock price to reach $186.44 in the next twelve months. This suggests that the stock has a possible downside of 17.0%.
View analysts' price targets for Irhythm Technologies
.

Who are some of Irhythm Technologies' key competitors?

What other stocks do shareholders of Irhythm Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Irhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), salesforce.com (CRM), Square (SQ), Teladoc Health (TDOC), Trade Desk (TTD), Advanced Micro Devices (AMD), Intel (INTC), Broadcom (AVGO) and The Boeing (BA).

Who are Irhythm Technologies' key executives?

Irhythm Technologies' management team includes the following people:
  • Mr. Kevin M. King, Pres, CEO & Director (Age 63)
  • Mr. Matthew C. Garrett, Chief Financial Officer (Age 51)
  • Mr. David A. Vort, Exec. VP of Sales (Age 53)
  • Dr. Derrick Sung, Exec. VP of Strategy & Corp. Devel. (Age 46)
  • Mr. Karim Karti, Chief Operating Officer (Age 50)

When did Irhythm Technologies IPO?

(IRTC) raised $76 million in an initial public offering on Thursday, October 20th 2016. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is Irhythm Technologies' stock symbol?

Irhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC."

Who are Irhythm Technologies' major shareholders?

Irhythm Technologies' stock is owned by many different institutional and retail investors. Top institutional shareholders include Alberta Investment Management Corp (0.22%), CWM LLC (0.09%), Envestnet Asset Management Inc. (0.04%), Spearhead Capital Advisors LLC (0.01%), Altium Wealth Management LLC (0.00%) and Mitchell Sinkler & Starr PA (0.00%). Company insiders that own Irhythm Technologies stock include Bruce G Bodaken, David A Vort, Derrick Sung, Kevin M King, Mark J Day, Matthew C Garrett, Merz Cathleen Noel Bairey, Ralph Snyderman and Raymond W Scott.
View institutional ownership trends for Irhythm Technologies
.

Which institutional investors are selling Irhythm Technologies stock?

IRTC stock was sold by a variety of institutional investors in the last quarter, including CWM LLC, and Arden Trust Co. Company insiders that have sold Irhythm Technologies company stock in the last year include David A Vort, Kevin M King, Mark J Day, Matthew C Garrett, Ralph Snyderman, and Raymond W Scott.
View insider buying and selling activity for Irhythm Technologies
.

Which institutional investors are buying Irhythm Technologies stock?

IRTC stock was bought by a variety of institutional investors in the last quarter, including Alberta Investment Management Corp, Altium Wealth Management LLC, Mitchell Sinkler & Starr PA, Fieldpoint Private Securities LLC, Fulton Bank N. A., Abbot Financial Management Inc., Nisa Investment Advisors LLC, and Envestnet Asset Management Inc..
View insider buying and selling activity for Irhythm Technologies
.

How do I buy shares of Irhythm Technologies?

Shares of IRTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Irhythm Technologies' stock price today?

One share of IRTC stock can currently be purchased for approximately $224.64.

How big of a company is Irhythm Technologies?

Irhythm Technologies has a market capitalization of $6.48 billion and generates $214.55 million in revenue each year. The company earns $-54,570,000.00 in net income (profit) each year or ($2.16) on an earnings per share basis. Irhythm Technologies employs 748 workers across the globe.

What is Irhythm Technologies' official website?

The official website for Irhythm Technologies is www.irhythmtech.com.

How can I contact Irhythm Technologies?

Irhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The company can be reached via phone at 415-632-5700 or via email at [email protected]

This page was last updated on 10/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.